Robert Shellenbarger

Robert Shellenbarger, CPA has a diverse work experience in finance and accounting roles. Robert currently holds the position of Senior Director Finance at Beam Therapeutics, a role they assumed in January 2024. Prior to this, they served as the Director of Finance at Beam Therapeutics from June 2022 to February 2024.

Before joining Beam Therapeutics, Robert worked at Novartis Gene Therapies as an Assistant Controller from January 2021 to June 2022. Robert also has experience working as a Senior Manager FP&A at AveXis, Inc. from November 2019 to January 2021.

Their earlier roles include Business Finance Manager, Commercial Finance Manager, Senior Commercial Analyst, and Senior Financial Analyst - Operations at Arysta LifeScience from November 2017 to November 2019, July 2016 to November 2017, July 2015 to June 2016, and May 2012 to June 2015 respectively.

Prior to Arysta LifeScience, Robert worked at IBM as a Cost Accounting Team Lead from March 2011 to May 2012.

Robert Shellenbarger, CPA has a Bachelor of Science degree in Social Studies, with a field of study in Secondary Education and Teaching from Penn State University. Robert also holds a Master of Business Administration degree, specializing in Accounting and Finance, from St. Bonaventure University.